Boston Scientific Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Boston Scientific's Inventory turnover ratio has remained unchanged compare to previous quarter at 2.15 in the first quarter 2026Average processing period, for Boston Scientific's inventories remained unchanged at 170 days, in the Mar 31 2026 quarter.

Within Healthcare sector 183 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 550 in the fourth quarter 2025, to 1276.

BSX Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Boston Scientific Corporation Market Share?

What is Inventory Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Inventory Turnover▼

None ▼

Inventory Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

BSX Inventory Turnover Ratio	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter	(Mar 31 2025) I. Quarter
Y / Y Inventory Growth	8.72 %	4.73 %	6.1 %	9.7 %	11.95 %
Y / Y Cost of Sales Growth	9.43 %	9.69 %	16.08 %	28.9 %	20.18 %
Inventory Turnover Ratio (TTM)	2.15	2.15	2.12	2.08	1.99
BSX's Total Ranking	# 1276	# 550	# 519	# 580	# 1361
Average inventory processing period	170	170	172	176	183
Seq. Inventory Growth	5.91 %	0.75 %	2.1 %	-0.21 %	2.03 %
Seq. Cost of Sales Growth	-1.12 %	5.58 %	-6.96 %	12.66 %	-0.89 %

Inventory Turnover Ratio Company Ranking
Within:	No.
Medical Equipment & Supplies Industry	# 78
Healthcare Sector	# 184
Overall Market	# 1276

Inventory Turnover Ratio Statistics
High	Average	Low
3.46	2.54	1.77
(Sep. 30, 2005)		(March 31, 2014)

BSX Company Profile >> Back to BSX Efficiency Comparisons >> Compare BSX Inventory Turnover Ratio to its Competitors

Financial Statements
Boston Scientific's Inventories	$ 3,117 Millions	Visit BSX's Balance sheet
Boston Scientific's Cost of Revenues TTM	$ 6,358 Millions	Visit BSX's Income Statement
What are BSX's Sales?		Visit BSX's Sales by Segment

Other Inventory Turnover Ratios
Boston Scientific's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Equipment & Supplies Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
BSX's Inventory Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for BSX's Competitors
Inventory Turnover Ratio for BSX's Suppliers
Inventory Turnover Ratio for BSX's Customers

You may also want to know
BSX's Sales Growth Rates	BSX's Pe Price to earnings ratio	BSX's Receivables Turnover Ratio	BSX's Stock Quote
BSX's Net Income Growth Rates	BSX's Ps Price to Sales ratio	BSX's Sales per Employee	BSX's Asset Turnover Ratio
BSX's Net Margin	BSX's Pb Price to Book ratio	BSX's Financial Strength Ratios	BSX's Dividend Payout Ratio

Companies with similar Inventory Turnover Ratio for the quarter ending Mar 31 2026, within Healthcare Sector	Inventory Turnover Ratio	Cost of revenues at quarter ending Mar 31 2026	Inventories at quarter ending Mar 31 2026
Avantor Inc	5.55	$ 4,447.000 Millions	$ 801 Millions
Steris Plc	5.27	$ 3,309.400 Millions	$ 628 Millions
Bristol myers Squibb Company	5.24	$ 14,324.000 Millions	$ 2,735 Millions
Harrow Inc	5.11	$ 69.568 Millions	$ 14 Millions
Integer Holdings Corporation	5.11	$ 1,365.000 Millions	$ 267 Millions
Tactile Systems Technology Inc	5.08	$ 81.000 Millions	$ 16 Millions
Integrated Biopharma Inc	4.96	$ 45.000 Millions	$ 9 Millions
Ufp Technologies Inc	4.95	$ 436.000 Millions	$ 88 Millions
Polomar Health Services, Inc.	4.79	$ 0.642 Millions	$ 0 Millions
Henry Schein Inc	4.70	$ 9,209.000 Millions	$ 1,959 Millions
Bionexus Gene Lab Corp	4.70	$ 4.191 Millions	$ 1 Millions
Medinotec Inc	4.69	$ 4.864 Millions	$ 1 Millions
West Pharmaceutical Services Inc	4.68	$ 2,052.000 Millions	$ 439 Millions
Scilex Holding Company	4.48	$ 14.462 Millions	$ 3 Millions
Guardant Health Inc	4.41	$ 379.203 Millions	$ 86 Millions
Idexx Laboratories Inc	4.38	$ 1,690.942 Millions	$ 386 Millions
Envista Holdings Corporation	4.36	$ 1,267.000 Millions	$ 290 Millions
Zai Lab Limited	4.32	$ 190.383 Millions	$ 44 Millions
Inotiv Inc	4.25	$ 175.895 Millions	$ 41 Millions
Cryoport inc	4.23	$ 96.609 Millions	$ 23 Millions
Teva Pharmaceutical Industries Limited	4.22	$ 8,317.000 Millions	$ 1,971 Millions
Incyte Corporation	4.21	$ 403.465 Millions	$ 96 Millions
Electromed Inc	4.16	$ 14.195 Millions	$ 3 Millions
Vericel Corporation	4.15	$ 73.494 Millions	$ 18 Millions
Sharps Technology Inc	4.12	$ 3.585 Millions	$ 1 Millions
Coherus Oncology inc	4.11	$ 14.975 Millions	$ 4 Millions
Novocure Limited	4.08	$ 167.287 Millions	$ 41 Millions
Lifeward ltd	4.08	$ 13.275 Millions	$ 3 Millions
Ge Healthcare Technologies Inc	4.04	$ 9,262.000 Millions	$ 2,294 Millions
Koru Medical Systems Inc	3.99	$ 16.468 Millions	$ 4 Millions

Date modified: 2026-09-08T15:11:40+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.